Search

Search Results

• SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

  Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs

  e2024006

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.006

  1236

  PDF: 1321

  HTML: 252

• THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

  Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini

  e2016025

  2016-05-01

  https://doi.org/10.4084/mjhid.2016.025

  6405

  PDF: 2166

  HTML: 14135

  Untitled: 210

  figure: 195

• SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

  Massimo Breccia, Giuliana Alimena

  e2014003

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.003

  3333

  PDF: 1240

  HTML: 3520

• Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.

  Maria Dmitrievna Sanatko

  e2012047

  2012-06-30

  https://doi.org/10.4084/mjhid.2012.047

  2469

  PDF: 885

  HTML: 703

  Untitled: 238

• PROPHYLAXIS OF MALARIA

  Eli Schwartz

  e2012045

  2012-06-29

  https://doi.org/10.4084/mjhid.2012.045

  3070

  PDF: 1058

  HTML: 17931

  Figures SChwartz: 178

• PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA

  Roberto Stasi, Lian Wea Chia, Pallavi Kalkur, Robert Lown, Muriel S. Shannon

  e2009023

  https://doi.org/10.4084/mjhid.2009.023

  892

  PDF: 601

  HTML: 1461

• The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

  Shuku Sato

  e2025070

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.070

  1383

  PDF: 453

  HTML: 115

• AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA

  Suparak Para, Puncharee Mungkalasut, Makamas Chanda, Issarang Nuchprayoon, Srivicha Krundsood, Chalisa Louicharoen Cheepsunthorn

  e2018015

  2018-02-16

  https://doi.org/10.4084/mjhid.2018.015

  3316

  PDF: 921

  HTML: 467

  Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 206

• VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis

  Alexandros Makis, Sophia Tsabouri, Paraskevi Karagouni, Maria Rogalidou, Irene Sionti, Nikolaos Chaliasos

  e2017011

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.011

  3215

  PDF: 809

  HTML: 1545

• Transfusion associated peak in Hb HPLC chromatogram – a case report

  Sonal Jain, Jasmita Dass, Hara Prasad Pati

  e2012006

  2012-01-21

  https://doi.org/10.4084/mjhid.2012.006

  1101

  PDF: 790

  HTML: 2788

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2523

  PDF: 804

  HTML: 1743

• EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

  Slaheddine Fattoum

  e2009005

  2009-10-27

  1072

  PDF: 438

  HTML: 15053

• Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

  Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

  e2025026

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.026

  2030

  PDF: 1708

  HTML: 223

• THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

  Elvira Pelosi, Dr. Germana Castelli, Ugo Testa

  e2022080

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.080

  1566

  PDF: 1191

  HTML: 529

• SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

  Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini

  e2021046

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.046

  1451

  PDF: 768

  HTML: 435

• THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY

  Kun Yang, Yi Wu, Yali Zhou, Tianhong Zhou, Li Wang, Zhili Geng, Xiaolin Yin

  e2020021

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.021

  2282

  PDF: 1275

  HTML: 396

• LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

  Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis

  e2014025

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.025

  2309

  PDF: 2181

  HTML: 2487

• VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

  Ashraf Tawfik Soliman

  e2013057

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.057

  2789

  PDF: 1106

  HTML: 2593

• IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

  Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos

  e2012052

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.052

  3118

  PDF: 893

  HTML: 7289

  Kost Fig1: 202

  Kost Fig 2: 191

  Kost Fig3: 194

  Kost Fig 4: 206

  Kost Fig5: 205

  Kost fig 6: 190

• SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

  Matteo Molica

  e2024079

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.079

  970

  PDF: 534

  HTML: 217

• Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major

  Kun Yang

  e2023053

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.053

  748

  PDF: 581

  HTML: 187

• TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

  Agustin Avilès, Maria-Jesus Nambo, Natividad Neri

  e2018006

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.006

  3809

  PDF: 1104

  HTML: 903

• Skin Manifestations associated with Mantle cell Lymphoma: a case report

  avinash kumar singh, Gaurav Dixit, sanjeev sharma, rajni yadav, Narendra agrawaal, chitra sarkar, pravas mishra, Tulika seth, manoranjan mahapatra, Renu saxena

  e2013020

  2013-02-24

  https://doi.org/10.4084/mjhid.2013.020

  1597

  PDF: 787

  HTML: 2180

  Untitled: 234

  Untitled: 206

  Untitled: 204

  Untitled: 215

  Untitled: 208

• Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

  Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu

  e2025038

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.038

  1095

  PDF: 766

  HTML: 110

• Hyperhemolytic Syndrome complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 alloimmunization, in a pregnant woman with HbO-Arab?-thalassemia

  Zoe Bezirgiannidou, Anna Christoforidou, Eftychia Kontekaki, Athanasios Anastasiadis, Spyros Papamichos, Helen Menexidou, Dimitrios Margaritis, George Martinis, Elpidoforos Mandadakis

  e2016053

  2016-10-18

  https://doi.org/10.4084/mjhid.2016.053

  3238

  PDF: 932

  HTML: 1287

  Figure 1: 176

• THE UTILITY OF BLOOD AND BONE MARROW FILMS AND TREPHINE BIOPSY SECTIONS IN THE DIAGNOSIS OF PARASITIC INFECTIONS

  Clare Miller, Barbara Bain

  e2015039

  2015-05-26

  https://doi.org/10.4084/mjhid.2015.039

  1808

  PDF: 1181

  HTML: 21534

• SHORT TERM ADVANTAGES OF A PUBLIC-PRIVATE PARTNERSHIP FOR TUBERCULOSIS IN GUINEA BISSAU: REDUCTION OF MORTALITY AND INCREASED DIAGNOSTIC CAPACITY

  Fina Vieira, Mamadu Saliu Sanha, Fabio Riccardi, Raffaella Colombatti

  e2014049

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.049

  1443

  PDF: 939

  HTML: 1304

  Untitled: 193

• EFFECT OF CIS ACTING POTENTIAL REGULATORS IN THE ß GLOBIN GENE CLUSTER ON THE PRODUCTION OF HBF IN THALASSEMIA PATIENTS

  Anita Nadkarni

  e2013012

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.012

  1249

  PDF: 613

  HTML: 3382

• OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

  Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz

  e2012011

  2012-02-10

  https://doi.org/10.4084/mjhid.2012.011

  1153

  PDF: 555

  HTML: 1702

  Figures: 181

  Fifures Sanz: 188

  tables Sanz: 190

  Untitled: 185

• Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

  Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain

  e2010012

  2010-05-31

  https://doi.org/10.4084/mjhid.2010.012

  1084

  PDF: 706

  HTML: 375

• Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

  Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani

  e2024004

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.004

  1485

  PDF: 1442

  HTML: 211

• Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

  Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso

  e2022058

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.058

  1723

  PDF: 801

  HTML: 295

• ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

  Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko

  e2018014

  2018-02-15

  https://doi.org/10.4084/mjhid.2018.014

  5323

  PDF: 1975

  HTML: 1733

• MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

  Ibrahim C. Haznedaroglu

  e2014009

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.009

  4079

  PDF: 1564

  HTML: 9238

  Untitled: 288

  Untitled: 196

  Untitled: 181

  Untitled: 174

  Untitled: 197

  Untitled: 353

• CLASSIC KSHV/HHV-8-POSITIVE PRIMARY EFFUSION LYMPHOMA (PEL): A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

  Ilaria Cozzi, Giovanni Rossi, Emma Rullo, Valeria Ascoli

  e2022020

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.020

  1613

  PDF: 990

  HTML: 421

• Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance

  Holly Lee, Peter Duggan, Ernesta Paola Neri, Jason Tay, Victor Jimenez Zepeda

  e2019007

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.007

  2329

  PDF: 1194

  HTML: 377

• ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

  Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed

  e2017026

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.026

  2549

  PDF: 930

  HTML: 1437

  Untitled: 239

• HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

  Mazyar Shadman, Joachim Deeg

  e2014056

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.056

  2095

  PDF: 786

  HTML: 3250

• Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young type 3

  Valentina Bozzoli, Maria Chiara Tisi, Luigi Pianese, Stefano Tumini, Vittoria Rufini, Maria Lucia Calcagni, Dario Pitocco, Alberto Larghi, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili, Francesco D'Alò, Stefan Hohaus

  e2012005

  2012-01-18

  https://doi.org/10.4084/mjhid.2012.005

  1565

  PDF: 732

  HTML: 982

• Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis

  Federico Marzi, Mario Alessandri, Veronica De Crescenzo, Stefania Del Vecchio, Simone Radi, Maurizio Manini

  e2026037

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.037

  312

  HTML: 108

  PDF: 140

• CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

  Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone

  e2024010

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.010

  4477

  PDF: 3672

  HTML: 367

• EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015

  Elmoubasher Farag, Devendra Bansal, Mohamad Abdul Halim Chehab, Ayman Al-Dahshan, Mohamed Bala, Nandakumar Ganesan, Yosuf Abdulla Al Abdulla, Mohammed Al Thani, Ali H. Sultan, Hamad Al-Romaihi

  e2018050

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.050

  2014

  PDF: 1031

  HTML: 482

• How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

  Marco Sanna, Giovanni Caocci, Giorgio La Nasa

  e2017047

  2017-08-14

  https://doi.org/10.4084/mjhid.2017.047

  1865

  PDF: 933

  HTML: 1018

  Referring article: 760

• DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY

  Dibyendu De, Uttam Kumar Nath

  e2015028

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.028

  2448

  PDF: 1121

  HTML: 2179

  Untitled: 182

• REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio

  e2012053

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.053

  2375

  PDF: 1023

  HTML: 7691

  Untitled: 292

  Fig2: 195

  Fig3: 188

  Fig4: 198

• Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

  Serdar Sivgin

  e2013006

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.006

  1184

  PDF: 644

  HTML: 3340

• ATRA induced Reactive Hemophagocytosis: A Case Report

  Monica Sharma, Sanjeev Kumar Sharma, Jasmita Dass, Seema Tyagi

  e2011034

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.034

  1260

  PDF: 612

  HTML: 2903

  ATRA induced Reactive Hemophagocytosis: A Case Report: 209

• CLASSICAL HODGKIN LYMPHOMA TODAY

  Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.055

  560

  PDF: 382

  HTML: 117

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1601

  PDF: 1414

  HTML: 139

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  2135

  PDF: 1741

  HTML: 927